Several diseases specific to South Asian populations had been identified in the past, but the genetic causes of the vast majority remained largely mysterious.
The study, led by Harvard Medical School (HMS) in the US and the CSIR - Centre for Cellular and Molecular Biology (CCMB) in Hyderabad, reveals that so-called founder events - in which a small number of ancestors give rise to many descendants - significantly contributed to high rates of population-specific, recessive diseases in the region.
"Much of the focus of genetic research in India has been on diseases such as diabetes, thalassemia or sickle cell anaemia that are prevalent across populations," said Kumarasamy Thangaraj, a scientist at the CCMB.
"But that misses the huge burden of disease caused by rare conditions," said Thangaraj, co-senior author of the study published in the journal Nature Genetics.
"This is an opportunity to improve health for many in the Indian subcontinent," he said.
The Indian subcontinent is one of the most genetically diverse places on Earth, with a population approaching 1.5 billion that includes nearly 5,000 well-defined subgroups, researchers said.
They analysed genome-wide data from more than 2,800 people from over 260 South Asian subgroups and found that nearly one-third of these subgroups derived from distinctive founder events.
This can lead to the perpetuation and proliferation of certain rare, recessive diseases, researchers said.
"Everybody carries a small number of mutations that could cause severe disease, but each person usually only has one copy - and two copies are needed to get sick," said the study's first author, Nathan Nakatsuka, a graduate student in the Reich lab.
"If parents have the same common ancestry, there is a greater risk that they will both carry the same recessive mutation, so their offspring are at much greater risk of inheriting the two copies needed to manifest disease," said Nakatsuka.
In the West, studies of similarly isolated populations have resulted in the discovery of many disease-causing genetic variants.
This has led to screening practices that have reduced the incidence of disease. The most well-known examples are tests that screen people of Ashkenazi Jewish descent for the genetic variants that cause Tay-Sachs disease.
Discovering disease-inducing genetic variants could lead to prenatal screenings to prevent disease, researchers said.
Efforts to screen for carrier status for disease variants have reduced the rate of rare recessive disease to almost zero in Western "founder" communities that practice arranged marriage, such as ultra-Orthodox Ashkenazi Jews.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
